ArticleThe Eurasian journal of medicine2024
Cancer Patients' Use of Apitherapy as Supportive Care: An Exploratory Study.
Article in The Eurasian journal of medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study was conducted to determine the cancer patients' use of apitherapy as supportive care.
methodsThis descriptive research was carried out between January 2019 and January 2020 at the oncology unit of a university hospital. Power analysis was used to determine the sample size of the study, and a total of 87 patients constituted the sample of the research with a CI of 85%. A questionnaire consisting of questions investigating the sociodemographic characteristics of the patients and their knowledge, opinions, and practices about apitherapy was used to collect the data. The data were analyzed using descriptive statistics and the Statistical Package of Social Sciences 21 package program.
resultsThe level of knowledge of the patients about apitherapy is quite low (41.4%), and they received the information they gained from their family/friends (63.9%). The rate of use of apitherapy products by patients is low (27.6%), and the most frequently used product is honey (37.4%). Patients stated that apitherapy products should be used to support cancer treatment (57.5%) and should be used in consultation with a physician (54.0%). The patients who use apitherapy products the most are those with breast cancer.
conclusionIn order for apitherapy to be used as a support in cancer treatment, it is important for healthcare professionals to guide patients about the areas of use of apitherapy and its safe use.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.